Lothar H. Wieler

show This article may be expanded with text translated from the corresponding article in German. (June 2021) Click [show] for important translation instructions. View a machine-translated version of the German article. Machine translation like DeepL or Google Translate is a useful starting point for translations, but translators must revise errors as necessary and confirm that the translation is accurate, rather than simply copy-pasting machine-translated text into the English Wikipedia. Consider adding a topic to this template: there are already 6,533 articles in the main category, and specifying|topic= will aid in categorization. Do not translate text that appears unreliable or low-quality. If possible, verify the text with references provided in the foreign-language article. You must provide copyright attribution in the edit summary accompanying your translation by providing an interlanguage link to the source of your translation. A model attribution edit summary Content in this edit is translated from the existing German Wikipedia article at [[:de:Lothar H. Wieler]]; see its history for attribution. You should also add the template {{Translated|de|Lothar H. Wieler}} to the talk page. For more guidance, see Wikipedia:Translation.

Lothar H. Wieler
Lothar H. Wieler (2016)
Born	Lothar Heinz Wieler (1961-02-08) 8 February 1961 (age 60) Königswinter, West Germany (now Germany)
Nationality	German
Scientific career
Fields	Veterinary medicine Microbiology
Website	www.rki.de/SharedDocs/Lebenslauf/Wieler_Lothar_H.html

Lothar Heinz Wieler (born 8 February 1961 in Königswinter, Germany) is a German veterinarian and microbiologist who has been serving as president of the Robert Koch Institute (RKI) since 2015.^[1] In this capacity, he advises the German Federal and State Governments on topics of public health, especially infection hazards, and on the containment of the COVID-19 pandemic.^[2]

Early life and education[]

Wieler studied veterinary medicine at Free University of Berlin and Ludwig Maximilian University of Munich from 1980 to 1985.^[3]

Career[]

From 1998 until 2015, Wieler worked as professor and director of the Institute of Microbiology and Epizootics at the Free University of Berlin.^[4] During that time, he spent a sabbatical at the Wellcome Sanger Institute in Hinxton under the supervision of Gordon Dougan.^[5]

Early in the COVID-19 pandemic in Germany, Wieler launched Europe’s first large-scale SARS-CoV-2 antibody testing in an effort to help researchers assess infection rates and monitor the spread of the virus more effectively; the study was carried out jointly by the Robert Koch Institute, Charité and the Helmholtz Centre for Infection Research.^[6]

In addition to his role at RKI, Wieler has been a member of the World Health Organization's Strategic and Technical Advisory Group for Infectious Hazards (STAG-IH) since 2018.^[7] In 2020, he chaired the WHO's Committee for the Review of the International Health Regulations.^[8] Also in 2020, he was appointed to the Global Leaders Group on Antimicrobial Resistance, co-chaired by Sheikh Hasina and Mia Mottley.^[9]

Other activities[]

• World Health Organization (WHO), Member of the European Advisory Committee on Health Research (since 2018)^[10]
• Global Research Collaboration for Infectious Disease Preparedness (GloPID-R), Member of the Scientific Advisory Board (since 2016)
• Fraunhofer Institute for Telecommunications, Member of the Board of Trustees^[11]
• Robert Koch Foundation, Member of the Scientific Advisory Council^[12]

References[]

This article about a German biologist is a stub. You can help Wikipedia by .

• v
• t